Pay in 4 interest-free payments of $25.00 Learn more
Ships within 48 hours · Estimated delivery Aug 16 - Aug 21
The pharmacology of fenbufen
0 mg/kg DAC in combination with 167 mg/kg Tetrahydrouridine in animals
Smiles: C[C@]12CC[C@@H](C[C@H]1CC[C@@H]1[C@@H]2C[C@@H](O)[C@]2(C)[C@H](CC[C@@]21O)C1COC(=O)C=1)O[C@H]1C[C@H](O)[C@H](O[C@H]2C[C@H](O)[C@H](O[C@H]3C[C@H](O)[C@H](O[C@@H]4O[C@H](CO)[C@@H](O)[C@H](O)[C@H]4O)[C@@H](C)O3)[C@@H](C)O2)[C@@H](C)O1
InChiKey: PMKHEKMZTWMVJX-UHFFFAOYSA-N
DS-1205b free base 9984A The pharmacology of fenbufenDS 1205b free base is a potent and selective inhibitor of AXL kinase, with an IC50 of 1. 3 nM. DS 1205b free base also inhibits MER, MET, and TRKA, with IC50s of 63, 104, and 407 nM, respectively. DS 1205b free base can inhibit cell migration in vitro and tumor growth in vivo. Product information CAS Number: 1855860 24 0 Molecular Weight: 735. 80 Formula: C41H42FN5O7 Chemical Name: N {4 [2 amino 5 (4 {[(2R) 1,4 dioxan 2 yl]methoxy} 3